
Navigating Neuropsychology 202 | Neuromodulation – A Conversation With Dr. Noah Philip
Nov 1, 2026
Dr. Noah Philip, a Brown University professor and Providence VA psychiatrist, explores the expanding world of neuromodulation. They discuss how TMS targets brain circuits, accelerated treatment protocols, safety, and its potential for depression and OCD. The conversation also examines focused ultrasound for reaching deep structures, the promise of precision psychiatry, and neuropsychology’s evolving role in brain-based care.
AI Snips
Chapters
Transcript
Episode notes
Why TMS Targets the Dorsolateral Prefrontal Cortex
- TMS protocols use intermittent pulses because neurons respond to change more readily than static fields.
- The dorsolateral prefrontal cortex became a depression target partly by historical sequencing, even though it regulates circuits implicated across many disorders.
TMS Has A Favorable Systemic Safety Profile
- TMS showed clinically meaningful superiority to sham in treatment-resistant depression, while real-world clinics may see roughly two-thirds of patients improve somewhat.
- Unlike many medications, its common adverse effects are local discomfort and noise rather than weight gain, diabetes, or sexual side effects.
Recalibrate TMS When Seizure Risk Changes
- Recheck the motor threshold whenever sleep, mood, medications, or substance use may have changed cortical excitability.
- Seizures remain rare, but stimulant use, alcohol withdrawal, sleep deprivation, and high medication doses can increase risk.
